glp-1 cardiovascular outcomes trial results august 2025 SGLTi and in HF The Big Trial of a

Monitor for hypoglycemia if used with glucose-lowering medications and avoid use in those with a history of pancreatitis

Injectable and oral GLP-1 formulations have not been formally studied in nursing populations

Attributing someones PCOS solely to their weight creates unfair blame and shame, she says

Few specific treatments have been approved solely for the treatment of PWS

The bold move has been accompanied by a full-page ad in the Wall Street Journal explaining its reasoning, and claiming that the prices of GLP-1 drugs for weight loss are five times too high and need to be brought in line with levels in other countries

For women living with obesity or weight-related health conditions, this approval represents an important expansion of treatment choice and reflects the continued evolution of obesity care